320
Participants
Start Date
April 15, 2019
Primary Completion Date
December 31, 2019
Study Completion Date
March 1, 2020
Retrospective observational study- no intervention to occur.
Subject data will be grouped based on the anti-fibrotic medication at the time of lung transplant listing eligibility and when medication was stopped relative to the transplant.
University of Pennsylvania, Philadelphia
Temple University, Philadelphia
Duke University, Durham
Cleveland Clinic, Cleveland
University of Iowa, Iowa City
Washington University in St. Louis, St Louis
Massachusetts General Hospital, Boston
Brigham and Women's Hospital, Boston
Collaborators (1)
Boehringer Ingelheim
INDUSTRY
Steward St. Elizabeth's Medical Center of Boston, Inc.
OTHER